July 05, 2009
Home
About
Submit Press Release
PR Firms
Editors/Journalists
Search Archives
 
News Releases by Category  
News by Country  
News by MSA  
All News for Today  
Browse News by Day  
News by Trackbacks  
All Press Releases for December 2, 2008 Subscribe to this News Feed  
 

FFF Enterprises Unveils ‘The 8 Critical Steps to Guaranteed Channel Integrity’ at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Orlando

Download this press release as an Adobe PDF document.

At this year's ASHP midyear meeting, FFF Enterprises, the nation's largest and most trusted distributor of critical-care biopharmaceuticals and vaccines, will unveil its best practices model for supply chain integrity and demonstrate how the company has taken pharmaceutical distribution to a new level. (Booth #1439)

(Vocus) December 2, 2008 -- At this year's ASHP midyear meeting, FFF Enterprises, the nation's largest and most trusted distributor of critical-care biopharmaceuticals and vaccines, will unveil its best practices model for supply chain integrity and demonstrate how the company has taken pharmaceutical distribution to a new level. (Booth #1439)

More than a company that moves product from point A to point B, FFF Enterprises, Inc., the nation’s largest and most trusted distributor of plasma products, vaccines and critical-care biopharmaceuticals, has taken pharmaceutical distribution to a new level. With its "Patients First" philosophy that guides every decision it makes, FFF has made the uncompromising decision to purchase only from the manufacturer and sell only to certified healthcare providers, with 6 additional steps in between, to assure that patients are always the first consideration as products move through its safe channel.

We are creating a standard for safety and excellence that we hope will continue to have a positive influence on the industry as a whole

ASHP Tradeshow Booth
ASHP Tradeshow Booth

These best practices, which FFF calls The 8 Critical Steps to Guaranteed Channel Integrity™, are crucial to ensuring that patient safety, product efficacy and fair pricing are not compromised anywhere in the supply chain.

Impacting America's pharmaceutical distribution system is precisely what FFF has set as its mission. Having just celebrated its 20th anniversary, and with a perfect safety track record of more than 20 counterfeit-free years, FFF is pleased to unveil The 8 Critical Steps to Guaranteed Channel Integrity at the upcoming ASHP midyear meeting in Orlando, Florida, Dec. 7 – 11, Booth #1439.

"Each step in the 8 steps is critical, it's absolutely essential to the others, to make sure we do not compromise, in any way, patient safety," states Patrick M. Schmidt, chief executive officer, FFF Enterprises. "We are creating a standard for safety and excellence that we hope will continue to have a positive influence on the industry as a whole," he continues.

FFF has clearly set itself apart as an industry leader that goes Beyond Distribution in several ways. Examples include innovative technologies such as the industry's first Verified Electronic Pedigree™ (VEP) system to electronically display the chain of custody for every product that moves through its safe channel, its LotTrack™ service to track products by lot number and provide recall notification to those affected, as well as its MyFluVaccine™ program, which has revolutionized the flu vaccine marketplace.

In addition, FFF provides customers and partners with meaningful communications such as IG Living, the only magazine targeted directly to immune globulin patients and their healthcare providers, its award-winning BioSupply trends e-newsletters, updates, community and flu alerts, and GPO-specific e-newsletters.

FFF's Wow! Customer Care is aptly named, with a responsive, passionate and caring team of knowledgeable professionals that includes customer care representatives, advisors, advocates and a nationwide field team of territory managers to take care of customers needs.

You may visit FFF at ASHP in Orlando at Booth #1439.

About FFF Enterprises, Inc.:
FFF Enterprises, Inc., FFF Enterprises a privately held corporation, is the largest and most trusted distributor of plasma products, vaccines and other biopharmaceuticals in the U.S. Founded in 1988, FFF is celebrating its 20th year with more than a billion dollars in annual sales and a flawless safety track record. FFF's Guaranteed Channel Integrity™ ensures that products are purchased only from the manufacturer and shipped only to healthcare providers, protecting patients and manufacturers from counterfeit risks and pricing irregularities inherent in secondary and gray market channels. FFF’s proprietary technologies, Verified Electronic Pedigree™ and Lot-Track™, provide verification of this secure channel. FFF's MyFluVaccine (www.MyFluVaccine.com) has revolutionized the flu marketplace, offering a dedicated flu vaccine supply, delivered to customers on the date of their choosing, and offering certainty in a volatile market segment. FFF's ability to move rapidly in a dynamically changing marketplace allows the creation of new opportunities for customers through innovative vehicles for distribution.

###

Trackback URL: http://www.prweb.com/pingpr.php/VGhpci1JbnNlLU1hZ24tRmFsdS1Mb3ZlLVNpbmctWmVybw==


See the original story at: http://www.prweb.com/releases/2008/12/prweb1693544.htm
Email this story to a colleague
Printer Friendly Version
Bookmark with del.icio.us
Bookmark with Y!MyWeb
Submit to Digg
Sheryl Perez
FFF Enterprises, Inc.
(800) 843-7477 x135
Email us Here

Celebrating 20 Counter-feit Free Years
Celebrating 20 Counter-feit Free Years
Uploaded: Dec 1, 2008
File Name: 0_FFFLogo.JPG

If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2007, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright